Medicamen Biotech Limited (NSE:MEDICAMEQ)

Market Cap	4.25B -27.3%
Revenue (ttm)	1.72B -4.5%
Net Income	77.66M +5.3%
EPS	5.84 -4.0%
Shares Out	n/a
PE Ratio	54.68
Forward PE	n/a
Dividend	1.00 (0.29%)
Ex-Dividend Date	Sep 19, 2025

Volume	19,995
Average Volume	19,505
Open	338.20
Previous Close	333.20
Day's Range	319.60 - 338.45
52-Week Range	292.95 - 560.70
Beta	0.46
RSI	39.83
Earnings Date	Feb 13, 2026

About Medicamen Biotech

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarials, vitamins, antibiotics, and supplements, other generics, and pain management. The company was incorporated in 1993 and is based in New Delhi,...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 376
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MEDICAMEQ

Financial Performance

In fiscal year 2025, Medicamen Biotech's revenue was 1.68 billion, a decrease of -6.56% compared to the previous year's 1.79 billion. Earnings were 71.08 million, a decrease of -34.97%.